(Q37150322)

18 August 2017

1 reference

title

Age-related decline in immunity: implications for vaccine responsiveness (English)

1 reference

18 August 2017

1 reference

Rajesh Kumar

1

1 reference

18 August 2017

Edith A Burns

series ordinal

2

1 reference

18 August 2017

publication date

1 May 2008

1 reference

Expert Review of Vaccines

18 August 2017

published in

1 reference

18 August 2017

volume

7

1 reference

18 August 2017

issue

4

1 reference

18 August 2017

page(s)

467-479

1 reference

Immunosenescence: emerging challenges for an ageing population

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Immunity and ageing in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Immunizations in the elderly: do they live up to their promise?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Innate immunity in aging: impact on macrophage function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

BIOLOGY OF HEMATOPOIETIC STEM CELLS AND PROGENITORS: Implications for Clinical Application

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Cellular memory and hematopoietic stem cell aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Quantitative genetic variation in the hematopoietic stem cell and progenitor cell compartment and in lifespan are closely linked at multiple loci in BXD recombinant inbred mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Genome maintenance mechanisms for preventing cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Aging of the immune system: a risk factor for autoimmunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Age-dependent changes in thymic macrophages and dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

T cell development, ageing and Interleukin-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Aging, immunity and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Replicative senescence of CD8 T cells: effect on human ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

In vitro senescence of immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

The cytomegalovirus-specific CD4+ T-cell response expands with age and markedly alters the CD4+ T-cell repertoire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination--an impact of immunosenescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Altered cytokine production in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

The immune system in the elderly: II. Specific cellular immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Inflammatory cytokines overcome age-related defects in CD4 T cell responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Development and function of naturally occurring CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Regulatory T cells in virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Natural regulatory T cells in infectious disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Role of regulatory T cells in human diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

CD4+CD25+Foxp3+ T cells and CD4+CD25-Foxp3+ T cells in aged mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Aging and developmental transitions in the B cell lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Transitional B cells: step by step towards immune competence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

The affinity and spectrum of cross reactivity of anti-body production in senescent mice: The IgM response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Ageing, autoimmunity and arthritis: senescence of the B cell compartment - implications for humoral immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Immunosenescence and germinal center reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Distinctive characteristics of germinal center B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Relative contribution of T and B cells to hypermutation and selection of the antibody repertoire in germinal centers of aged mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

The immune system in the elderly: III. Innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Immunosenescence and macrophage functional plasticity: dysregulation of macrophage function by age-associated microenvironmental changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Innate immunity and organ transplantation: the potential role of toll-like receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Immunosenescence of macrophages: reduced MHC class II gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Primary and secondary alterations of immune reactivity in the elderly: impact of dietary factors and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Ageing is associated with a decline in peripheral blood CD56bright NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

NK and NK/T cells in human senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Annual summary of vital statistics: 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Mortality associated with influenza and respiratory syncytial virus in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Immunity and immunization in elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

The influence of staff and resident immunization rates on influenza-like illness outbreaks in nursing homes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Immunodominant peptides from conserved influenza proteins--a tool for more efficient vaccination in the elderly?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Stress responses and innate immunity: aging as a contributory factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Dehydroepiandrosterone (DHEA) treatment reverses the impaired immune response of old mice to influenza vaccination and protects from influenza infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

The influence of sequential annual vaccination and of DHEA administration on the efficacy of the immune response to influenza vaccine in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

The use of oral dehydroepiandrosterone sulfate as an adjuvant in tetanus and influenza vaccination of the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Aspirin and salicylate suppress polymorphonuclear apoptosis delay mediated by proinflammatory stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Influenza and pneumococcal vaccination of the elderly: newer vaccines and prospects for clinical benefits at the margin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Revaccination with pneumococcal vaccine of elderly persons 6 years after primary vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Polysaccharide-protein conjugates: a new generation of vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Varicella and herpes zoster. Changing concepts of the natural history, control, and importance of a not-so-benign virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Clinical practice. Herpes zoster

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Epidemiology of varicella zoster virus infection in Canada and the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Postherpetic neuralgia--pathogenesis, treatment, and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Pain and its persistence in herpes zoster

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Immunization to reduce the frequency and severity of herpes zoster and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Zoster vaccine live (Oka/Merck).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Varicella-zoster virus vaccine: a review of its use in the prevention of herpes zoster in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Varicella-zoster vaccine for the prevention of herpes zoster

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Augmenting immune responses to varicella zoster virus in older adults: a randomized, controlled trial of Tai Chi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Influence of age and physical activity on the primary in vivo antibody and T cell-mediated responses in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Hepatitis A virus infection in the United States: serologic results from the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Hepatitis A vaccines and the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Cancer vaccines: preclinical studies and novel strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Modifications increasing the efficacy of recombinant vaccines; marked increase in antibody titers with moderately repetitive variants of a therapeutic allergy vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Delivery systems and adjuvants for oral vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Adjuvants: present regulatory challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Antioxidant vitamins E and C as adjunct therapy of severe acute lower-respiratory infection in infants and young children: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Nutrition and immune function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

The role of growth hormone in modulation of the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

The somatopause: an indication for growth hormone therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Doping with growth hormone/IGF-1, anabolic steroids or erythropoietin: is there a cancer risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

100 years and counting: prospects for defeating Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Insights into the mechanisms of action of anti-Abeta antibodies in Alzheimer's disease mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Transcutaneous beta-amyloid immunization reduces cerebral beta-amyloid deposits without T cell infiltration and microhemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

Immunity for tumors and microbes after autotransplantation: if you build it, they will (not) come

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.467

21 January 2018

Identifiers

DOI

10.1586/14760584.7.4.467

1 reference

18 August 2017

1 reference